Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-19

FDA Approved: PAZOPANIB — Original Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's pazopanib as an original ANDA (generic) approval. The approval covers a generic version of pazopanib for the established indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pazopanib (Pazopanib)

Snippet

ORIG AP for PAZOPANIB (PAZOPANIB)